Loading clinical trials...
Loading clinical trials...
EVOLVE 4.5/5.0 is a prospective, single-arm, multi-center observational (standard of care) trial intended to confirm the safety and effectiveness of the SYNERGY 4.50 mm and 5.00 mm Coronary Stent Syst...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boston Scientific Corporation
NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis
NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more
NCT05867381 · Air Pollution, Atherosclerosis
NCT06779630 · Coronary Artery Disease
NCT07565805 · Coronary Artery Disease (CAD)
Yale New Haven Hospital
New Haven, Connecticut
Clearwater Cardiovascular Consultants
Clearwater, Florida
Beth Israel Deaconness Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions